BDTX vs BHVN

Black Diamond Therapeutics, Inc vs Biohaven Ltd. — Valuation Comparison 2026

BDTX

Biotechnology
Black Diamond Therapeutics, Inc
Quality
6.8
out of 10
Value Trap
30
LOW
Price
$2.25
Last close
Models
10/13
Active
VS

BHVN

Biotechnology
Biohaven Ltd.
Quality
3.8
out of 10
Value Trap
30
LOW
Price
$10.24
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType BDTX Fair ValueBDTX Upside BHVN Fair ValueBHVN Upside
Bayesian DCF Intrinsic $2.84 -72.3%
Earnings Power Value Intrinsic $4.63 +64.1%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $1.92 -45.8%
Dynamic NAV Asset-Based $1.87 -16.8% $2.20 -78.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BDTX vs BHVN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BDTX vs BHVN — Which Stock Is More Undervalued?

BDTX scores higher with a 6.8/10 quality rating vs BHVN's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Black Diamond Therapeutics, Inc (BDTX) and Biohaven Ltd. (BHVN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BDTX currently trades at $2.25 with a QOC of 6.8/10, while BHVN trades at $10.24 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).